PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.75%
Net income growth under 50% of ORCL's 55.24%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
10.57%
D&A growth well above ORCL's 2.27%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-9.52%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
8.11%
SBC growth while ORCL is negative at -100.00%. John Neff would see competitor possibly controlling share issuance more tightly.
-222.37%
Both reduce yoy usage, with ORCL at -181.64%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-192.16%
Both yoy AR lines negative, with ORCL at -100.00%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
132.38%
Some yoy usage while ORCL is negative at -336.48%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
169.79%
Well above ORCL's 43.94%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-22.30%
Both yoy CFO lines are negative, with ORCL at -77.71%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-36.27%
Negative yoy CapEx while ORCL is 20.69%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
91.98%
Acquisition spending well above ORCL's 80.77%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
-5.34%
Both yoy lines negative, with ORCL at -17.97%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-24.17%
We reduce yoy sales while ORCL is 26.92%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-492.86%
We reduce yoy other investing while ORCL is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
53.52%
Investing outflow well above ORCL's 46.38%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
261.46%
Stock issuance far above ORCL's 15.14%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
-38.46%
We cut yoy buybacks while ORCL is 6.98%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.